Plasma interleukin-37 is elevated in patients with rheumatoid arthritis: Its correlation with disease activity and Th1/Th2/Th17-related cytokines

Disease Markers

Volumn 2015, Issue , 2015, Pages

  Xia, Ting ^a   Zheng, Xing Feng ^a   Qian, Bao Hua ^a   Fang, He ^a   Wang, Jun Jie ^a   Zhang, Lan Ling ^a   Pang, Ya Fei ^a   Zhang, Ju ^a   Wei, Xiao Qing ^b   Xia, Zhao Fan ^a   Zhao, Dong Bao ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 37; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; CCL2 PROTEIN, HUMAN; IL37 PROTEIN, HUMAN; INTERLEUKIN 1; TUMOR NECROSIS FACTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DAS28; DISEASE ACTIVITY; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNE RESPONSE; MALE; PATHOGENESIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TH1 CELL; TH17 CELL; TH2 CELL; BLOOD; CASE CONTROL STUDY; HELPER CELL; METABOLISM; MIDDLE AGED; PATHOLOGY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; BIOMARKERS; CASE-CONTROL STUDIES; CHEMOKINE CCL2; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-1; MALE; MIDDLE AGED; T-LYMPHOCYTES, HELPER-INDUCER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84943381629     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2015/795043     Document Type: Article

References (35)

1. F. M. Brennan and I. B. McInnes. Evidence that cytokines play a role in rheumatoid arthritis. Journal of Clinical Investigation, vol. 118, no. 11, pp. 3537-3545, 2008
2. M. Feldmann and R. N. Maini. The role of cytokines in the pathogenesis of rheumatoid arthritis. Rheumatology, vol. 38, supplement 2, pp. 3-7, 1999
3. M. F. Nold, C.A. Nold-Petry, J. A. Zepp, B. E. Palmer, P. Bufler, and C. A. Dinarello. IL-37 is a fundamental inhibitor of innate immunity. Nature Immunology, vol. 11, no. 11, pp. 1014-1022, 2010
4. M. Feldmann, F. M. Brennan, and R. N. Maini. Role of cytokines in rheumatoid arthritis. Annual Review of Immunology, vol. 14, pp. 397-440, 1996
5. I. B. McInnes and G. Schett. Cytokines in the pathogenesis of rheumatoid arthritis. Nature Reviews Immunology, vol. 7, no. 6, pp. 429-442, 2007
6. A. Burska, M. Boissinot, and F. Ponchel. Cytokines as biomarkers in rheumatoid arthritis. Mediators of Inflammation, vol. 2014, Article ID 545493, 24 pages, 2014
7. A.-M. Bulau, M. F. Nold, S. Li et al. Role of caspase-1 in nuclear translocation of IL-37, release of the cytokine, and IL-37 inhibition of innate immune responses. Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 7, pp. 2650-2655, 2014
8. A.-M. Bulau, M. Fink, C. Maucksch et al. In vivo expression of interleukin-37 reduces local and systemic inflammation in concanavalin A-induced hepatitis. TheScientificWorldJOURNAL, vol. 11, pp. 2480-2490, 2011
9. E. N. McNamee, J. C. Masterson, P. Jedlicka et al. Interleukin 37 expression protects mice from colitis. Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 40, pp. 16711-16716, 2011
10. N. Sakai, H. L. van Sweringen, R. M. Belizaire et al. Interleukin-37 reduces liver inflammatory injury via effects on hepatocytes and non-parenchymal cells. Journal of Gastroenterology and Hepatology, vol. 27, no. 10, pp. 1609-1616, 2012
11. Y. Yang, Z.-X. Zhang, D. Lian, A. Haig, R. N. Bhattacharjee, and A. M. Jevnikar. IL-37 inhibits IL-18-induced tubular epithelial cell expression of pro-inflammatory cytokines and renal ischemia-reperfusion injury. Kidney International, vol. 87, no. 2, pp. 396-408, 2015
12. F. J. Patel, D. T. Volkmann, G. W. Taylor et al. IL-37 reduces inflammatory response after cerebral ischemia and reperfusion injury through down-regulation of pro-inflammatory cytokines. Cytokine, vol. 69, no. 2, pp. 234-239, 2014
13. D. B. Ballak, J. A. van Diepen, A. R. Moschen et al. IL-37 protects against obesity-induced inflammation and insulin resistance. Nature Communications, vol. 5, article 4711, 2014
14. S. Moretti, S. Bozza, V. Oikonomou et al. IL-37 inhibits inflammasome activation and disease severity inmurine aspergillosis. PLoS Pathogens, vol. 10, no. 11, Article ID e1004462, 2014
15. X. Teng, Z. Hu, X. Wei et al. IL-37 ameliorates the inflammatory process in psoriasis by suppressing proinflammatory cytokine production. Journal of Immunology, vol. 192, no. 4, pp. 1815-1823, 2014
16. H. Fujita, Y. Inoue, K. Seto, N. Komitsu, and M. Aihara. Interleukin-37 is elevated in subjects with atopic dermatitis. Journal of Dermatological Science, vol. 69, no. 2, pp. 173-175, 2013
17. C. Li, H. Ji, Y. Cai et al. Serum interleukin-37 concentrations and HBeAg seroconversion in chronic HBV patients during telbivudine treatment. Journal of Interferon and Cytokine Research, vol. 33, no. 10, pp. 612-618, 2013
18. C. Li, P. Zhao, X. Sun, Y. Che, and Y. Jiang. Elevated levels of cerebrospinal fluid and plasma interleukin-37 in patients with Guillain-Barŕe syndrome, "Mediators of Inflammation, vol. 2013, Article ID 639712, 9 pages, 2013
19. Y. Li, Z. Wang, T. Yu et al. Increased expression of IL-37 in patients with graves disease and its contribution to suppression of proinflammatory cytokines production in peripheral blood mononuclear cells. PLoS ONE, vol. 9, no. 9, Article ID e107183, 2014
20. S. Weidlich, A.-M. Bulau, T. Schwerd et al. Intestinal expression of the anti-inflammatory interleukin-1 homologue IL-37 in pediatric inflammatory bowel disease. Journal of Pediatric Gastroenterology and Nutrition, vol. 59, no. 2, pp. e18-e26, 2014
21. L. Song, F. Qiu, Y. Fan et al. Glucocorticoid regulates interleukin-37 in systemic lupus erythematosus. Journal of Clinical Immunology, vol. 33, no. 1, pp. 111-117, 2013
22. Z. Ye, C. Wang, J. Tang et al. Decreased interleukin-37 expression in vogt-koyanagi-harada disease and upregulation following immunosuppressive treatment. Journal of Interferon &Cytokine Research, vol. 35, no. 4, pp. 265-272, 2015
23. Z. Y. Wan, Z. Sun, F. Song et al. Downregulated interleukin 37 expression associated with aggravation of intervertebral disc degeneration. International Journal of Clinical and Experimental Pathology, vol. 7, no. 2, pp. 656-662, 2014
24. Z. Ye, C. Wang, A. Kijlstra, X. Zhou, and P. Yang. A possible role for interleukin 37 in the pathogenesis of Behcets disease. Current Molecular Medicine, vol. 14, no. 4, pp. 535-542, 2014
25. P.W. Zhao, W. Jiang, L. Wang et al. Plasma levels of IL-37 and correlation with TNF-β IL-17A, and Disease activity during DMARD treatment of rheumatoid arthritis. PLoS ONE, vol. 9, no. 5, Article IDe95346, 2014
26. P. Isomäki and J. Punnonen. Pro- and anti-inflammatory cytokines in rheumatoid arthritis. Annals of Medicine, vol. 29, no. 6, pp. 499-507, 1997
27. Y. Luo, X. Cai, S. Liu et al. Suppression of antigen-specific adaptive immunity by IL-37 via induction of tolerogenic dendritic cells. Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 42, pp. 15178-15183, 2014
28. Z. Huang, C. Gao, X. Chi et al. IL-37 expression is upregulated in patients with tuberculosis and induces macrophages towards an M2-like phenotype. Scandinavian Journal of Immunology, 2015
29. A. Di Stefano, G. Caramori, A. Barczyk et al. Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD. Thorax, vol. 69, no. 6, pp. 516-524, 2014
30. A. C. Horsfall, D. M. Butler, L. Marinova et al. Suppression of collagen-induced arthritis by continuous administration of IL-4. The Journal of Immunology, vol. 159, no. 11, pp. 5687-5696, 1997
31. R. Fellowes, C. J. Etheridge, S. Coade et al. Amelioration of established collagen induced arthritis by systemic IL-10 gene delivery. GeneTherapy, vol. 7, no. 11, pp. 967-977, 2000
32. J. M. Woods, K. J. Katschke Jr., M. Tokuhira et al. Reduction of inflammatory cytokines and prostaglandin E2 by IL-13 gene therapy in rheumatoid arthritis synovium. The Journal of Immunology, vol. 165, no. 5, pp. 2755-2763, 2000
33. E. Parks, R. M. Strieter, N. W. Lukacs et al. Transient gene transfer of IL-12 regulates chemokine expression and disease severity in experimental arthritis. Journal of Immunology, vol. 160, no. 9, pp. 4615-4619, 1998
34. C. A. Murphy, C. L. Langrish, Y. Chen et al. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. Journal of Experimental Medicine, vol. 198, no. 12, pp. 1951-1957, 2003
35. S. A. Y. Hartgring, C. R. Willis, J. W. J. Bijlsma, F. P. J. G. Lafeber, and J. A. G. van Roon. Interleukin-7-Aggravated joint inflammation and tissue destruction in collagen-induced arthritis is associated with T-cell and B-cell activation. Arthritis Research andTherapy, vol. 14, no. 3, article R137, 2012